content: <HTML>
  <HEAD>
  <TITLE></TITLE>
  </HEAD>
  <BODY STYLE="font-size: 10pt">
  
  
  <P STYLE="margin: 0; text-align: center; text-indent: 0"></P>
  
  <P STYLE="margin: 0; text-align: center">SECURITIES AND EXCHANGE COMMISSION</P>
  
  <P STYLE="margin: 0; text-align: center">Washington, D.C. 20549</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center">FORM 8-K</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center">CURRENT REPORT</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center">Pursuant to Section 13 or 15(d)</P>
  
  <P STYLE="margin: 0; text-align: center">of the Securities Exchange Act of 1934</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Date of Report (date of earliest event
  reported):</P>
  
  <P STYLE="margin: 0; text-align: center">August 10, 2015</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="background-color: white">
      <TD COLSPAN="5" STYLE="border-bottom: black 1pt solid; padding-bottom: 10pt; text-align: center; line-height: 115%"><B>EVENT
      CARDIO GROUP INC.</B></TD></TR>
  <TR STYLE="background-color: white">
      <TD COLSPAN="5" STYLE="padding-bottom: 10pt; text-align: center; line-height: 115%">(Exact name of registrant as specified
      in its charter)</TD></TR>
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="width: 30%; border-bottom: black 1pt solid; padding-bottom: 10pt; text-align: center; line-height: 115%"><B>Nevada</B></TD>
      <TD STYLE="width: 5%; padding-bottom: 10pt; text-align: center; line-height: 115%">&nbsp;</TD>
      <TD STYLE="width: 30%; border-bottom: black 1pt solid; padding-bottom: 10pt; text-align: center; line-height: 115%"><B>0-52518</B></TD>
      <TD STYLE="width: 5%; padding-bottom: 10pt; text-align: center; line-height: 115%">&nbsp;</TD>
      <TD STYLE="width: 30%; border-bottom: black 1pt solid; padding-bottom: 10pt; text-align: center; line-height: 115%"><B>20-8051714</B></TD></TR>
  <TR>
      <TD STYLE="padding-bottom: 10pt; text-align: center; line-height: 115%">(State or other jurisdiction of Incorporation)</TD>
      <TD STYLE="vertical-align: top; padding-bottom: 10pt; text-align: center; line-height: 115%">&nbsp;</TD>
      <TD STYLE="padding-bottom: 10pt; text-align: center; line-height: 115%">(Commission File Number)</TD>
      <TD STYLE="vertical-align: top; padding-bottom: 10pt; text-align: center; line-height: 115%">&nbsp;</TD>
      <TD STYLE="padding-bottom: 10pt; text-align: center; line-height: 115%">(I.R.S. Employer Identification No.)</TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="width: 45%; border-bottom: black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>2798 Thamesgate Dr.</B></P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Mississauga, Ontario, Canada</B></P></TD>
      <TD STYLE="width: 10%; padding-bottom: 10pt; text-align: center; line-height: 115%">&nbsp;</TD>
      <TD STYLE="width: 45%; border-bottom: black 1pt solid; padding-bottom: 10pt; text-align: center; line-height: 115%"><B>L4T
      4E8</B></TD></TR>
  </TABLE>
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;Check the appropriate box below if the Form 8-K filing is intended to simultaneously
  satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 15pt; text-align: right">&bull;</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</TD>
  </TR></TABLE>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 15pt; text-align: right">&bull;</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17&nbsp;&nbsp;&nbsp;CFR
  240.14a-12)</TD>
  </TR></TABLE>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 15pt; text-align: right">&bull;</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
  CFR 240.14d-2(b))</TD>
  </TR></TABLE>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 15pt; text-align: right">&bull;</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
  CFR 240.13e-4(c))</TD>
  </TR></TABLE>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <!-- Field: Page; Sequence: 1 -->
      <DIV STYLE="margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin: 0; text-align: justify"></P>
  
  <P STYLE="margin: 0; text-align: justify"><B>Item 3.02 Sale of Unregistered Securities.</B></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 20pt">The Company has entered into Subscription
  Agreements with four investors whereby it received an aggregate of $110,000. The investors include affiliates of two of its principal
  shareholders, a Partner of counsel to the Company and a non-affiliated shareholder who previously invested $100,000 in the Company.
  In consideration of an investment of $20,000, each of the affiliated shareholders and the Company&#8217;s counsel received 400,000
  shares of the Company&#8217;s common stock and warrants to purchase 400,000 shares of common stock, exercisable for a period of
  four years at ten cents ($0.10) per share. For his investment of $50,000 the unrelated shareholder received 1,000,000 shares of
  common stock and warrants to purchase 1,000,000 shares of common stock, exercisable for a period of four years at ten cents ($0.10)
  per share</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 20pt">The Company will pay approximately $80,000
  of the $110,000 gross proceeds received from the investments described above to Contex Engineering to further the development
  of its Now Cardio device.</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 20pt">The issuance and sale of the shares of
  common stock and warrants were exempt from the registration requirements of the Securities Act under Rule 506 of Regulation D.
  Each of the investors is an accredited investor within the meaning of Rule 501(a) of Regulation D. No brokers were involved in
  the offering and sale of the securities. A legend restricting the sale, transfer or other disposition of the securities except
  pursuant to registration under the Securities Act or an exemption therefrom was imprinted on the certificates evidencing the securities.</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 10%; line-height: 115%"><B>Item&nbsp;9.01</B></TD>
      <TD STYLE="width: 90%; line-height: 115%"><B>&nbsp;Financial Statements and Exhibits.</B></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 3%; line-height: 115%"><B>(d)</B></TD>
      <TD STYLE="width: 97%; line-height: 115%"><B>Exhibits.</B></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
      <TD COLSPAN="1"><B>Exhibit Number &nbsp; Description</B></TD></TR>
  </TABLE>
  
  
  
  <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 15pt; text-align: right">10.1</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><A HREF="ecgi8k081315ex10_1.htm">Form of Subscription Agreement between the Company and each of Lori Burke, Taunton Ravenscroft, Inc. and Vincent McGill</A></TD>
  </TR></TABLE>
  
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 15pt; text-align: right">10.2</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><A HREF="ecgi8k081315ex10_2.htm">Form of Subscription Agreement between the Company and Louis Solferino</A></TD>
  </TR></TABLE>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 15pt; text-align: right">10.3</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><A HREF="ecgi8k081315ex10_3.htm">Form of Warrant issued to Lori Burke, Taunton Ravenscroft, Inc., Vincent McGill and Louis Solferino.</A></TD>
  </TR></TABLE>
  
  
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <!-- Field: Page; Sequence: 2 -->
      <DIV STYLE="margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin: 0; text-align: justify"></P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">SIGNATURES</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 20pt">Pursuant
  to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
  by the undersigned hereunto duly authorized.</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">Dated: August 13, 2015</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
      <TD STYLE="line-height: 115%">&nbsp;</TD>
      <TD COLSPAN="2" STYLE="line-height: 115%">EVENT CARDIO GROUP INC.</TD>
      <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 52%; line-height: 115%">&nbsp;</TD>
      <TD STYLE="width: 2%; line-height: 115%">&nbsp;</TD>
      <TD STYLE="width: 35%; line-height: 115%">&nbsp;</TD>
      <TD STYLE="width: 11%; line-height: 115%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="line-height: 115%">&nbsp;</TD>
      <TD STYLE="line-height: 115%">By:</TD>
      <TD STYLE="border-bottom: black 1.5pt solid; line-height: 115%">/s/&nbsp;John Bentivoglio</TD>
      <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
  <TR>
      <TD STYLE="vertical-align: top; line-height: 115%">&nbsp;</TD>
      <TD STYLE="vertical-align: top; line-height: 115%">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; line-height: 115%">John Bentivoglio</TD>
      <TD STYLE="vertical-align: top; line-height: 115%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="line-height: 115%">&nbsp;</TD>
      <TD STYLE="line-height: 115%">&nbsp;</TD>
      <TD STYLE="line-height: 115%">Chief Executive Officer</TD>
      <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
  </TABLE>
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
  
  <!-- Field: Page; Sequence: 3; Options: Last -->
      <DIV STYLE="margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"></P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>
  
  <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>
  
  <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>
  
  <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>
  
  <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>
  
  <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&#9;</P>
  
  <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>
  
  <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>
  
  <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>
  
  <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>
  
  <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>
  
  <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>
  
  <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>
  
  
  </BODY>
  </HTML>
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "ecgi8k081315.htm", "secsgml_size_bytes": 14472}]
metadata_filer: {"company-data": {"conformed-name": "Event Cardio Group Inc.", "cik": "0001394130", "assigned-sic": "1000", "irs-number": "208051714", "state-of-incorporation": "NV", "fiscal-year-end": "0831"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-52518", "film-number": "151051954"}, "business-address": {"street1": "2798 THAMESGATE DR.", "city": "MISSISSAUGA", "state": "A6", "zip": "L4T 4E8", "phone": "289-407-4377"}, "mail-address": {"street1": "2798 THAMESGATE DR.", "city": "MISSISSAUGA", "state": "A6", "zip": "L4T 4E8"}, "former-company": [{"former-conformed-name": "Sunrise Holdings LTD", "date-changed": "20080404"}, {"former-conformed-name": "Sunrise Mining CORP", "date-changed": "20070322"}]}
text: SECURITIES AND EXCHANGE COMMISSION
  Washington, D.C. 20549
  FORM 8-K
  CURRENT REPORT
  Pursuant to Section 13 or 15(d)
  of the Securities Exchange Act of 1934
  Date of Report (date of earliest event
  reported):
  August 10, 2015
  EVENT
      CARDIO GROUP INC.
  (Exact name of registrant as specified
      in its charter)
  Nevada
  0-52518
  20-8051714
  (State or other jurisdiction of Incorporation)
  (Commission File Number)
  (I.R.S. Employer Identification No.)
  2798 Thamesgate Dr.
  Mississauga, Ontario, Canada
  L4T
      4E8
  Check the appropriate box below if the Form 8-K filing is intended to simultaneously
  satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
  •
  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  •
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17   CFR
  240.14a-12)
  •
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
  CFR 240.14d-2(b))
  •
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
  CFR 240.13e-4(c))
  Item 3.02 Sale of Unregistered Securities.
  The Company has entered into Subscription
  Agreements with four investors whereby it received an aggregate of $110,000. The investors include affiliates of two of its principal
  shareholders, a Partner of counsel to the Company and a non-affiliated shareholder who previously invested $100,000 in the Company.
  In consideration of an investment of $20,000, each of the affiliated shareholders and the Company's counsel received 400,000
  shares of the Company's common stock and warrants to purchase 400,000 shares of common stock, exercisable for a period of
  four years at ten cents ($0.10) per share. For his investment of $50,000 the unrelated shareholder received 1,000,000 shares of
  common stock and warrants to purchase 1,000,000 shares of common stock, exercisable for a period of four years at ten cents ($0.10)
  per share
  The Company will pay approximately $80,000
  of the $110,000 gross proceeds received from the investments described above to Contex Engineering to further the development
  of its Now Cardio device.
  The issuance and sale of the shares of
  common stock and warrants were exempt from the registration requirements of the Securities Act under Rule 506 of Regulation D.
  Each of the investors is an accredited investor within the meaning of Rule 501(a) of Regulation D. No brokers were involved in
  the offering and sale of the securities. A legend restricting the sale, transfer or other disposition of the securities except
  pursuant to registration under the Securities Act or an exemption therefrom was imprinted on the certificates evidencing the securities.
  Item 9.01
  Financial Statements and Exhibits.
  (d)
  Exhibits.
  Exhibit Number   Description
  10.1
  Form of Subscription Agreement between the Company and each of Lori Burke, Taunton Ravenscroft, Inc. and Vincent McGill
  10.2
  Form of Subscription Agreement between the Company and Louis Solferino
  10.3
  Form of Warrant issued to Lori Burke, Taunton Ravenscroft, Inc., Vincent McGill and Louis Solferino.
  SIGNATURES
  Pursuant
  to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
  by the undersigned hereunto duly authorized.
  Dated: August 13, 2015
  EVENT CARDIO GROUP INC.
  By:
  /s/ John Bentivoglio
  John Bentivoglio
  Chief Executive Officer